Gene: VSIG2

23584
2210413P10Rik|CTH|CTXL
V-set and immunoglobulin domain containing 2
protein-coding
11q24.2
Ensembl:ENSG00000019102 MIM:606011 Vega:OTTHUMG00000150357 UniprotKB:Q96IQ7
NC_000011.10
PubMed
0   ANCO-SNPs
ND|AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
1.373e-1 (AD)  2.302e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
AKAP80.716
ARAP30.707
ASXL10.688
MYO5C0.687
NCOA30.685
DENND30.685
TBC1D40.683
STX30.682
MAP3K30.682
PPP3CC0.681

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
BTBD17-0.377
DIAPH3-0.374
S100A1-0.35
LHFPL1-0.343
AKR7A3-0.342
LYPD1-0.337
PIPOX-0.323
WNT7B-0.318
MMD2-0.316
SLC22A6-0.315

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of VSIG2 gene27153756
D001280AtrazineAtrazine results in increased expression of VSIG2 mRNA22378314
C030935benz(a)anthracenebenz(a)anthracene results in decreased expression of VSIG2 mRNA26377693
C006780bisphenol Abisphenol A results in increased expression of VSIG2 mRNA22687993
C006780bisphenol Abisphenol A results in decreased expression of VSIG2 mRNA25181051
D002922CiguatoxinsCiguatoxins affects the expression of VSIG2 mRNA18353800
C069837fullerene C60fullerene C60 results in decreased expression of VSIG2 mRNA19167457
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of VSIG2 mRNA25613284
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of VSIG2 mRNA"25554681|2562005
D011794QuercetinQuercetin results in decreased expression of VSIG2 mRNA21632981
C059514resveratrolresveratrol results in increased expression of VSIG2 mRNA25436977
D053260SootSoot results in decreased expression of VSIG2 mRNA26551751
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of VSIG2 mRNA25613284
C015559trimellitic anhydridetrimellitic anhydride results in decreased expression of VSIG2 mRNA19042947
D001335Vehicle EmissionsVehicle Emissions affects the methylation of VSIG2 gene25560391

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
GO:0005887integral component of plasma membrane-TAS9862345  
GO:0016020membrane-TAS9862345  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal